Joint effect of mid- and late-life blood pressure on the brain: The AGES-Reykjavik Study

Neurology

Volumn 82, Issue 24, 2014, Pages 2187-2195

  Muller, Majon ^a,b   Sigurdsson, Sigurdur ^c   Kjartansson, Olafur ^c,d   Aspelund, Thor ^c   Lopez, Oscar L ^e   Jonnson, Palmi V ^d,f   Harris, Tamara B ^a   Van Buchem, Mark ^b   Gudnason, Vilmundur ^c   Launer, Lenore J ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ICELAND   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAIN; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN SIZE; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDUCATION; FEMALE; GRAY MATTER; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PULSE PRESSURE; SMOKING; SYSTOLIC BLOOD PRESSURE; WHITE MATTER; WHITE MATTER LESION;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; BLOOD PRESSURE; BRAIN; COGNITION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; HYPERTENSION; ICELAND; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RETROSPECTIVE STUDIES;

EID: 84903986737     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000517     Document Type: Article

References (33)

1. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358: 1887-1898.
2. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338: b1665.
3. Dufouil C, Chalmers J, Coskun O, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005;112: 1644-1650.
4. Godin O, Tzourio C, Maillard P, Mazoyer B, Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011;123: 266-273.
5. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive Function Assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7: 683-689.
6. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4: 487-499.
7. Muller M, Smulders YM, de Leeuw PW, Stehouwer CD. Treatment of hypertension in the oldest old: a critical role for frailty? Hypertension 2014;63: 433-441.
8. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function: The Honolulu-Asia Aging Study. JAMA 1995;274: 1846-1851.
9. Korf ES, White LR, Scheltens P, Launer LJ. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension 2004;44: 29-34.
10. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology 2011;77: 461-468.
11. Euser SM, van BT, Schram MT, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc 2009;57: 1232-1237.
12. Sabayan B, Oleksik AM, Maier AB, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc 2012;60: 2014-2019.
13. Strandgaard S, Paulson OB. Cerebrovascular consequences of hypertension. Lancet 1994;344: 519-521.
14. Muller M, van der Graaf Y, Visseren FL, Mali WP, Geerlings MI. Hypertension and longitudinal changes in cerebral blood flow: the SMART-MR study. Ann Neurol 2012;71: 825-833.
15. Iadecola C, Davisson RL. Hypertension and cerebrovascular dysfunction. Cell Metab 2008;7: 476-484.
16. Muller M, van der Graaf Y, Visseren FL, Vlek AL, Mali WP, Geerlings MI. Blood pressure, cerebral blood flow, and brain volumes: The SMART-MR study. J Hypertens 2010;28: 1498-1505.
17. Mitchell GF, van Buchem MA, Sigurdsson S, et al. Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility-Reykjavik study. Brain 2011;134: 3398-3407.
18. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med 2006;166: 1003-1008.
19. Muller M, van der Graaf Y, Algra A, Hendrikse J, Mali WP, Geerlings MI. Carotid atherosclerosis and progression of brain atrophy: the SMART-MR study. Ann Neurol 2011;70: 237-244.
20. Harris TB, Launer LJ, Eiriksdottir G, et al. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 2007;165: 1076-1087.
21. Sigurdsson S, Aspelund T, Forsberg L, et al. Brain tissue volumes in the general population of the elderly: the AGESReykjavik Study. Neuroimage 2012;59: 3862-3870.
22. Zijdenbos AP, Forghani R, Evans AC. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans Med Imaging 2002;21: 1280-1291.
23. Vidal JS, Sigurdsson S, Jonsdottir MK, et al. Coronary artery calcium, brain function and structure: the AGESReykjavik Study. Stroke 2010;41: 891-897.
24. Stewart R, Xue QL, Masaki K, et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension 2009;54: 233-240.
25. Veldink JH, Scheltens P, Jonker C, Launer LJ. Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology 1998;51: 319-320.
26. Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan Study. Stroke 2010;41: S103-S106.
27. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002;33: 21-25.
28. de Leeuw FE, de Groot JC, Oudkerk M, et al. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999;46: 827-833.
29. Den Heijer T, Skoog I, Oudkerk M, et al. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging 2003;24: 307-313.
30. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347: 1141-1145.
31. Jochemsen HM, Muller M, Visseren FL, et al. Blood pressure and progression of brain atrophy: the SMART-MR Study. JAMA Neurol 2013;70: 1046-1053.
32. Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke 2002;33: 1986-1992.
33. van Bemmel T, Holman ER, Gussekloo J, Blauw GJ, Bax JJ, Westendorp RG. Low blood pressure in the very old, a consequence of imminent heart failure: the Leiden 85-plus study. J Hum Hypertens 2009;23: 27-32.